> Details

Optimal dosing of a glycoprotein IIb/IIIa antagonist with a simplified renal-based algorithm: Pharmacodynamic and clinical findings from PARAGON B Christopher K. Dyke, Kenneth W. Mahaffey, Lisa G. Berdan, Magnus Ohman, Kristin Newby, Rodney A. Sparapani, Peter B. Berger, Neal S. Kleiman, Harvey D. White, Judith S. Hochman, Frans van de Werf, Paul W. Armstrong, Robert M. Califf, Robert A. Harrington, Eric J. Topol. Duke Clinical Research Institute, Durham, NC

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Optimal dosing of a glycoprotein IIb/IIIa antagonist with a simplified renal-based algorithm: Pharmacodynamic and clinical findings from PARAGON B Christopher K. Dyke, Kenneth W. Mahaffey, Lisa G. Berdan, Magnus Ohman, Kristin Newby, Rodney A. Sparapani, Peter B. Berger, Neal S. Kleiman, Harvey D. White, Judith S. Hochman, Frans van de Werf, Paul W. Armstrong, Robert M. Califf, Robert A. Harrington, Eric J. Topol. Duke Clinical Research Institute, Durham, NC
  • imprint: Elsevier BV, 2001
  • Published in: Journal of the American College of Cardiology
  • Language: English
  • DOI: 10.1016/s0735-1097(01)98351-2
  • ISSN: 0735-1097
  • Keywords: Cardiology and Cardiovascular Medicine
  • Origination:
  • Footnote:
  • Access State: Open Access